Ralph T Doyle
6PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 22, 2024
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.Neila Sayah, Deepak L Bhatt, Michael Miller
|Feb 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.Brian Olshansky, Deepak L Bhatt, Michael Miller
|Mar 09, 2022
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg
|Oct 28, 2021
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.Subodh Verma, Deepak L Bhatt, Ph Gabriel Steg
|Oct 28, 2021
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.Arjun Majithia, Deepak L Bhatt, Allon N Friedman
|Oct 03, 2020
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results.Brian Olshansky, Deepak L Bhatt, Michael Miller
Pageof 1
Frequent Collaborators
6 joint publications
Deepak L Bhatt
6 joint publications
Ph Gabriel Steg
6 joint publications
Eliot A Brinton
6 joint publications
Christie M Ballantyne
6 joint publications
Jean-Claude Tardif
5 joint publications
Michael Miller
5 joint publications
Rebecca A Juliano
4 joint publications
Terry A Jacobson
4 joint publications
Lixia Jiao
3 joint publications
Matthew J Budoff
